Post A Reply
my profile
login
|
register
|
search
|
faq
|
forum home
»
Allstocks.com's Bulletin Board
»
.11 and Up!
»
fonar value play
» Post A Reply
Post A Reply
Login Name:
Password:
Message Icon:
Message:
HTML is enabled.
UBB Code™ is enabled.
[QUOTE]Originally posted by raybond: [QB] larsstorkehave • 20 hours George Kesarious . George Kesarious just published an article on FONR at Seeking Alpha. I'm very disappointed with his article as it surprisingly lack depth and end up too superficial. GK has quit his investment in FONR at $18 and recommend buy below $15 and sell at $20. I conclude his sellout was in early January as FONR hasn't traded at $18 since. GK can't see FONR trade above $20 and his argument is no growth on product sales and anyone can make money on managing diagnostic centers. He also disagree on the decision to let the founders son be the new CEO. GK might be correct that the company isn't a takeover target with the few MRI sales. He also might have a point that FONR hasn't the potential to trade at $30-50 the next 12 month. I totally disagree with him on the target of #$%$20 and the CEO. My guess is, GK now feel obliged to explain why his predictions, recommendations and targets the last 2 years of $25-30 isn't met yet. I believe the record sales and EPS in Q2 2016 came as an complete surprise to him, and now he has to sustain his arguments from early January as he sold his FONR shares. In his article he expect an EPS about $2 over the next 12 month, but FONR's EPS the last 4 quarters has been $2.13 and improved qoq and yoy. If Q3 EPS is $0.44 as I expect, the last 12 month EPS is $2.26. Why then a setback to $2? In his article he is convinced the diagnostic revenue might have topped off already. Maybe that is his reason to expect lower EPS over the next 12 month. Next he doesn't comment on the opening of a new center which might increase diagnostic revenue further. Managements decision to open a new center definitely isn't in line with GK's argument of a diagnostic environment where revenue is in decline. The revenue excluding product sales/service/repairs the last 12 month of $59.8M or $3.5M above the previous 12 month of $56.3M is a pretty decent growth of 6.2%. My target on FONR based on an EPS of $2.5 over the next 12-15 month is unchanged $25-28. Less . . [/QB][/QUOTE]
Instant Graemlins
Instant UBB Code™
What is UBB Code™?
Options
Disable Graemlins in this post.
*** Click here to review this topic. ***
Contact Us
|
Allstocks.com Message Board Home
© 1997 - 2021 Allstocks.com. All rights reserved.
Powered by
Infopop Corporation
UBB.classic™ 6.7.2